10-Q
File 001-36242
10-Q
- Filing date
- 07 Aug 2015
- Reporting date
- 30 Jun 2015
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
DMK PHARMACEUTICALS Corp reports
- Company location
- San Diego, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996
SEC filing history
Showing 26-43 of 43 matching filings.
Per page
25
Current page
2
10-Q
File 001-36242
10-Q
- Filing date
- 14 May 2015
- Reporting date
- 31 Mar 2015
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 001-36242
QUARTERLY REPORT
- Filing date
- 14 Nov 2014
- Reporting date
- 30 Sep 2014
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 001-36242
QUARTERLY REPORT
- Filing date
- 13 Aug 2014
- Reporting date
- 30 Jun 2014
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 001-36242
QUARTERLY REPORT
- Filing date
- 14 Feb 2014
- Reporting date
- 31 Dec 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 13 Nov 2013
- Reporting date
- 30 Sep 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 19 Aug 2013
- Reporting date
- 30 Jun 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 19 Feb 2013
- Reporting date
- 31 Dec 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 13 Nov 2012
- Reporting date
- 30 Sep 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q/A
File 000-26372
AMENDED QUARTERLY REPORT
- Filing date
- 17 Aug 2012
- Reporting date
- 30 Jun 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 14 Aug 2012
- Reporting date
- 30 Jun 2012
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 14 Feb 2012
- Reporting date
- 31 Dec 2011
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 21 Nov 2011
- Reporting date
- 30 Sep 2011
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 15 Aug 2011
- Reporting date
- 30 Jun 2011
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 14 Feb 2011
- Reporting date
- 31 Dec 2010
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 18 Nov 2010
- Reporting date
- 30 Sep 2010
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 23 Aug 2010
- Reporting date
- 30 Jun 2010
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-26372
QUARTERLY REPORT
- Filing date
- 16 Feb 2010
- Reporting date
- 31 Dec 2009
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing